Reinventing Merck's Modern Lab: from pipettes to AI
Join Roy Helmy, Associate VP at Merck, as he explores what it takes to reinvent the lab from the ground up. From AI to end-to-end digital transformation of lab operations, Roy shares actionable insights on overcoming resistance and fostering collaboration, and why learning from f ...Afficher plus
Innovation Centers Powering Takeda's Digital Future
In this episode, host Tom Lehmann speaks with Sanjay Patel, Global Head of Innovation Capability Solutions & Services at Takeda, regarding how global collaboration and innovative leadership are reshaping the biotech landscape. Sanjay shares insights into the five-hub network he's ...Afficher plus
Épisodes Recommandés
Strategy& Insider Episode 27 - Bridging tradition and innovation with advanced computing
In this episode, Clemens Utschig-Utschig, CTO at Boehringer Ingelheim, guides us through the digital and technological transformation of a 140-year-old family-owned pharmaceutical company. Explore how he utilizes data and technology to revolutionize drug development and personali ...Afficher plus
Pharmaceutical Breakthroughs: The Cutting Edge of Biotechnology
"Pharmaceutical Breakthroughs: The Cutting Edge of Biotechnology" - In this episode, we dive deep into the revolutionary world of biotechnology and its transformative impact on pharmaceuticals. Discover how cutting-edge innovations are reshaping drug development, accelerating vac ...Afficher plus
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ...Afficher plus